SC
Scribe Therapeutics Inc.
SCTX · NASDAQ
$29.47 +0.55% (+$0.16)
1M +28.07%
Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 0.00x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SCTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Benjamin L. Oakes
Employees
89
Headquarters
Alameda